» Articles » PMID: 26061992

Natural Products Useful in Respiratory Disorders: Focus on Side-Effect Neutralizing Combinations

Overview
Journal Phytother Res
Publisher Wiley
Date 2015 Jun 11
PMID 26061992
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

This review summarizes literature related to medicinal plants reputed in traditional medical systems for treatment of asthma and coughs. The plants that are pharmacologically investigated for their effectiveness in such conditions, along with respective experimental protocol details, are also discussed. Some of plant origin compounds, which are considered useful as antitussive and antiasthmatic agents, are described as well. Chrysoeriol, a constituent of Aspalathus linearis (Fabaceae) was observed to be selective for relaxant effect in airways (through K channel activation), compared with other smooth muscles. We reported that Hypericum perforatum (Hyperieaceae), Andropogon muricatus (Poaceae), Juniper excelsa (Coniferae) and Nepeta cataria (Lamiaceae) exhibit bronchodilatory action, mediated through combination of Ca antagonist and phospohodiesrase inhibitory mechanisms, which scientifically explains their medicinal use in asthma. Hyocyamus niger (Solanaceae), Artemisia vulgaris (Compositae), Fumaria parviflora (Fumariaceae) and Terminalia bellerica (Combretaceae) caused bronchodilation via dual blockade of muscarinic receptors and Ca influx. Acorus calamus (Araceae), Carum roxburghianum (Apiaceae), Lens culinaris (Fabaceae) and Lepidium sativum (Cruciferae) mediate bronchodilatation through multiple pathways: anticholinergic and inhibition of Ca channels and PDE enzyme(s). In conclusion, this review presents an analysis of different novel combinations of pharmacological activities in medicinal plants with side effect-neutralizing/synergistic potential, setting new trends in the therapeutic options for hyperactive respiratory disorders such as asthma and cough. Copyright © 2015 John Wiley & Sons, Ltd.

Citing Articles

Efficacy and safety of Huaiqihuang granule as adjuvant treatment for primary nephrotic syndrome in children: a meta-analysis and systematic review.

Lin J, Huang L, Wang J, Mao J World J Pediatr. 2021; 17(3):242-252.

PMID: 34075551 DOI: 10.1007/s12519-020-00405-w.


Adjuvant treatment with Yupingfeng formula for primary nephrotic syndrome in children: A PRISMA systematic review and meta-analysis of randomized controlled trials.

Shi X, Zhong X, Ding J Medicine (Baltimore). 2018; 97(29):e11598.

PMID: 30024564 PMC: 6086467. DOI: 10.1097/MD.0000000000011598.


Antispasmodic, bronchodilator, vasorelaxant and cardiosuppressant effects of Buxus papillosa.

Khan A, Ali S, Gilani A, Ahmed M, Choudhary M BMC Complement Altern Med. 2017; 17(1):54.

PMID: 28100216 PMC: 5241935. DOI: 10.1186/s12906-017-1558-x.